MiR-448 was reported as a negative regulator of IDO and of the related differentiation of Tregs in breast cancer, while miR-142 played an important role in promoting an immunosuppressive TME through the induction of IFN-γ, leading to the expression of IDO in lymphatic endothelial cells [222,242]. The gene discussed is IDO1; the disease is breast carcinoma.